Mona Maftouh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mona Maftouh has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ahmadreza Tavassoli
Radiology Department, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications - Ali Teimouri
Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Behzad Aminzadeh
Mashhad University of Medical Sciences
1 shared publication - Farrokh Seilanian Toosi
Mashhad Univ Med Sci, Fac Med, Dept Radiol, Mashhad, Iran
1 shared publication - Mahdi Foroughian
Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication Malihe Hasanzade Mofrad
1 shared publication
Latest Publications
- Open Access
- 25 October 2021
- Published by Brieflands in International Journal of Cancer Management
- Vol. 14 (10)
Cutaneous Metastasis in a Previously Known Case of Ovarian Dysgerminoma: A Case Report
Introduction: Cutaneous metastasis is an uncommon manifestation that mostly occurs in patients with previous gastrointestinal or gynecological malignancies. Local recurrence usually can be seen in surgical incisions. Dysgerminomas are rare ovarian tumors that usually have local invasions, but metastases are infrequent. Here, we described a case of dysgerminoma and cutaneous metastasis in the surgical incision. Case Presentation: The patient was a 39-year-old woman previously known as ovarian dysgerminoma, who had undergone surgery one year ago. Ultrasound examination a year after surgery showed a 35 × 33 millimeters hypoechoic solid tumor in the left ovary and another 3 masses with similar echo pattern and vascularity were found in the surgical incision. Magnetic resonance imaging (MRI) findings were compatible with cutaneous metastasis of pervious dysgerminoma. Pathologic evaluation and Immunohistochemistry (IHC) confirmed dysgerminoma's skin metastasis. She received chemotherapy due to the recurrence of malignancy. Conclusions: Local recurrence and metastases (even in the skin) should be kept in mind and the clinician must examine the surgical site skin in patients with a history of malignancy.
- 25 October 2021
- Published by Brieflands in International Journal of Cancer Management
- Vol. 14 (10)
Open AccessCutaneous Metastasis in a Previously Known Case of Ovarian Dysgerminoma: A Case Report
Introduction: Cutaneous metastasis is an uncommon manifestation that mostly occurs in patients with previous gastrointestinal or gynecological malignancies. Local recurrence usually can be seen in surgical incisions. Dysgerminomas are rare ovarian tumors that usually have local invasions, but metastases are infrequent. Here, we described a case of dysgerminoma and cutaneous metastasis in the surgical incision. Case Presentation: The patient was a 39-year-old woman previously known as ovarian dysgerminoma, who had undergone surgery one year ago. Ultrasound examination a year after surgery showed a 35 × 33 millimeters hypoechoic solid tumor in the left ovary and another 3 masses with similar echo pattern and vascularity were found in the surgical incision. Magnetic resonance imaging (MRI) findings were compatible with cutaneous metastasis of pervious dysgerminoma. Pathologic evaluation and Immunohistochemistry (IHC) confirmed dysgerminoma's skin metastasis. She received chemotherapy due to the recurrence of malignancy. Conclusions: Local recurrence and metastases (even in the skin) should be kept in mind and the clinician must examine the surgical site skin in patients with a history of malignancy.
- Open Access
- 12 July 2021
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 18 (2)
Evaluation of the Prognostic Value of Chest Computed Tomography Scan in COVID-19 Patients
Background: The world is facing the coronavirus 2 pandemic since 2019 (COVID-19 infection) and all countries have challenges in management of patients based on their facilities. Chest computed tomography (CT) scan can be valuable in early detection and estimation of the pulmonary involvement in these patients. Objectives: To evaluate the prognostic value of chest CT imaging features in patients with coronavirus disease 2019 (COVID-19) pneumonia. Patients and Methods: In this cross-sectional study, 201 patients with COVID-19 were enrolled consecutively. The patients’ chest CT scans were analyzed, and the disease severity was rated using two methods: (1) total lung involvement (TLI) in which each lobe is scored from 0 to 4 based on the percentage of involvement; and (2) modified TLI in which each lobe involvement score is multiplied by the number of its segments, and the sum is recorded as the modified TLI. The patients were categorized into four groups depending on their prognosis (patients admitted to hospital wards, patients admitted to intensive care units [ICUs], patients with intubation during hospitalization, and expired patients). The relationship between both scoring methods and the clinical outcomes of patients was examined in the four groups. Results: The receiver operating characteristic (ROC) curve analysis showed no significant difference between the two scoring methods (TLI and modified TLI) in predicting the patients’ prognosis. The average disease severity based on the two scoring methods was significantly different between the four groups. Patients who were intubated during hospitalization and patients who expired had significantly higher scores than patients admitted to the ICUs and hospital wards (P = 0.001). The area under the ROC curve for the prediction of mortality was 0.81 (95% CI: 0.72 - 0.90; P < 0.001). The TLI score of 18.5 could predict mortality with specificity of > 95%. Conclusion: The TLI scoring system can be used for predicting in-hospital mortality and ICU admission in COVID-19 patients. This scoring method can help us devise a better strategic healthcare plan during the COVID-19 pandemic.
- 12 July 2021
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 18 (2)
Open AccessEvaluation of the Prognostic Value of Chest Computed Tomography Scan in COVID-19 Patients
Background: The world is facing the coronavirus 2 pandemic since 2019 (COVID-19 infection) and all countries have challenges in management of patients based on their facilities. Chest computed tomography (CT) scan can be valuable in early detection and estimation of the pulmonary involvement in these patients. Objectives: To evaluate the prognostic value of chest CT imaging features in patients with coronavirus disease 2019 (COVID-19) pneumonia. Patients and Methods: In this cross-sectional study, 201 patients with COVID-19 were enrolled consecutively. The patients’ chest CT scans were analyzed, and the disease severity was rated using two methods: (1) total lung involvement (TLI) in which each lobe is scored from 0 to 4 based on the percentage of involvement; and (2) modified TLI in which each lobe involvement score is multiplied by the number of its segments, and the sum is recorded as the modified TLI. The patients were categorized into four groups depending on their prognosis (patients admitted to hospital wards, patients admitted to intensive care units [ICUs], patients with intubation during hospitalization, and expired patients). The relationship between both scoring methods and the clinical outcomes of patients was examined in the four groups. Results: The receiver operating characteristic (ROC) curve analysis showed no significant difference between the two scoring methods (TLI and modified TLI) in predicting the patients’ prognosis. The average disease severity based on the two scoring methods was significantly different between the four groups. Patients who were intubated during hospitalization and patients who expired had significantly higher scores than patients admitted to the ICUs and hospital wards (P = 0.001). The area under the ROC curve for the prediction of mortality was 0.81 (95% CI: 0.72 - 0.90; P < 0.001). The TLI score of 18.5 could predict mortality with specificity of > 95%. Conclusion: The TLI scoring system can be used for predicting in-hospital mortality and ICU admission in COVID-19 patients. This scoring method can help us devise a better strategic healthcare plan during the COVID-19 pandemic.